z-logo
open-access-imgOpen Access
Primary breast tuberculosis in a man: a case report
Author(s) -
Bruce Shinga Wembulua,
Mady Ndiaye,
Aboubakar Sidikh Badiane,
Arielle Rita Belem,
Solohery Andriateloasy,
Ndèye Aïssatou Lakhe,
A. Dièye,
Viviane Marie Pierre Cissé Diallo,
Khardiata Diallo Mbaye,
Daye Kà,
L. Fortes Déguévo,
Moussa Seydi
Publication year - 2020
Publication title -
annales de biologie clinique
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.167
H-Index - 27
eISSN - 1950-6112
pISSN - 0003-3898
DOI - 10.1684/abc.2020.1537
Subject(s) - medicine , tuberculosis , granulomatous mastitis , genexpert mtb/rif , surgery , abscess , amoxicillin , metronidazole , mastitis , antibiotics , dermatology , mycobacterium tuberculosis , pathology , microbiology and biotechnology , biology
The breast tuberculosis accounts for 0.06 to 0.1% of extra-pulmonary localizations. Frequent in women, it remains exceptional in men. We report a rare case of primary breast tuberculosis occurring in a male patient. A 33-years-old patient presented with a chronic and fistulized non-inflammatory-right breast swelling with an atrophic cutaneous ulceration. The thoracic CT was in favor of a right breast abscess with a thick wall. The patient had received non-specific antibiotics (amoxicillin-clavulanate and metronidazole) for 10 days coupled with a surgical drainage before consulting us for persisting symptoms. The culture of the pus was sterile, the GeneXpert and the search for acid-fast bacilli (AFB) both performed on the swab of the ulceration were negative. Histopathological analysis of the lesion was in favor of a granulomatous mastitis. Given the chronic and atrophic nature of the ulceration, the histological aspect of granulomatous mastitis and the persisting symptoms despite the non-specific antibiotic therapy, we made a presumptive diagnostic of breast tuberculosis. The evolution was favorable with oral anti-tuberculosis treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here